Queensland’s Sunshine Coast Daily reports..

PAULINE Hanson has cemented her place in Queensland’s medicinal cannabis industry after throwing her support behind the state’s front-runner.

The outspoken One Nation leader said after she toured Sunshine Coast based company Medifarm’s facility, she wrote a letter of recommendation to the Office of Drug Control (ODC) backing the endeavour.

Medifarm were last week approved for a Medical Cannabis Manufacturing licence, the last needed for them to begin full operations.

“I’m very glad that I have been able to help this new industry secure a foothold in Queensland,” Ms Hanson said.

“Medical cannabis is a life changing medicine for many Australians and I’m proud to have been able to help the Sunshine Coast and Queensland lead the way in supplying it to Australians.”

One Nation have always been strong proponents of the controversial treatment, but this support is the latest move in their cannabis crusade.

Medifarm’s founding director Adam Benjamin said while he was grateful for Ms Hanson’s support, all tiers of government helped make the venture a reality.

“All the political parties in terms of Federally, State-wide and then at a Sunshine Coast Council have been very supportive,” he said.

“I personally, as well as a company have to applaud them.”

The company was granted a commercial cultivation and production licence from the Federal Government’s ODC earlier this year, but with their new manufacturing license they are legally able to see the cannabis through from planting to product.

“It was a staged process so yes, we needed this licence, but it just means now we well and truly will continue to establish the facility,” Mr Benjamin said.

“Now, we’re working with health authorities to make Queensland the leader in this space.”

More at  https://www.sunshinecoastdaily.com.au/news/pauline-hanson-throws-support-behind-coast-cannabi/3195338/

And if you are looking for a current state of play article in Australia from a US perspective  the editor at Cannabis Business Executive, David Hodes, has penned one here